Last 12 months
Inside the activity.
0 purchase rows · 25 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 14 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 4 |
| Oct 2026 | 0 | 2 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 01, 2021 Filed Sep 2, 2021 20:29 UTC |
DAWES KAREN ADirector
|
SaleCommon Stock | 239 | $280.27 | $66,984.53 |
DisclosureSEC source: 0000899243-21-034897 · doc4.xml · nonDerivative · entry 2 DAWES KAREN A · CIK 0001261506 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,141 F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on June 8, 2021. F2 · price: $280.27 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $279.90 to $280.60, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| September 01, 2021 Filed Sep 2, 2021 20:29 UTC |
DAWES KAREN ADirector
|
Exercise / conversionCommon Stock | 3,459 | $38.76 | $134,070.84 |
DisclosureSEC source: 0000899243-21-034897 · doc4.xml · nonDerivative · entry 1 DAWES KAREN A · CIK 0001261506 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,380 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on June 8, 2021. Read SEC document |
| August 30, 2021 Filed Sep 2, 2021 10:54 UTC |
KURIYEL RALFSenior VP, R&D
|
SaleCommon Stock | 4,001 | $282.13 | $1,128,802.13 |
DisclosureSEC source: 0000899243-21-034834 · doc4.xml · nonDerivative · entry 1 KURIYEL RALF · CIK 0001733143 · Senior VP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,354 F1 · price: $282.13 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $282.10 to $282.42, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| August 18, 2021 Filed Aug 19, 2021 20:42 UTC |
DAWES KAREN ADirector
|
SaleCommon Stock | 40 | $262.31 | $10,492.40 |
DisclosureSEC source: 0000899243-21-033643 · doc4.xml · nonDerivative · entry 11 DAWES KAREN A · CIK 0001261506 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,921 F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on June 8, 2021. Read SEC document |
| August 18, 2021 Filed Aug 19, 2021 20:42 UTC |
DAWES KAREN ADirector
|
SaleCommon Stock | 78 | $260.91 | $20,350.98 |
DisclosureSEC source: 0000899243-21-033643 · doc4.xml · nonDerivative · entry 10 DAWES KAREN A · CIK 0001261506 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,961 F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on June 8, 2021. F10 · price: $260.91 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $260.80 to $261.01, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| August 18, 2021 Filed Aug 19, 2021 20:42 UTC |
DAWES KAREN ADirector
|
SaleCommon Stock | 388 | $259.93 | $100,852.84 |
DisclosureSEC source: 0000899243-21-033643 · doc4.xml · nonDerivative · entry 9 DAWES KAREN A · CIK 0001261506 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,039 F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on June 8, 2021. F9 · price: $259.93 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $259.39 to $260.38, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| August 18, 2021 Filed Aug 19, 2021 20:42 UTC |
DAWES KAREN ADirector
|
SaleCommon Stock | 634 | $258.91 | $164,148.94 |
DisclosureSEC source: 0000899243-21-033643 · doc4.xml · nonDerivative · entry 8 DAWES KAREN A · CIK 0001261506 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,427 F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on June 8, 2021. F8 · price: $258.91 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $258.32 to $259.27, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| August 18, 2021 Filed Aug 19, 2021 20:42 UTC |
DAWES KAREN ADirector
|
SaleCommon Stock | 302 | $257.66 | $77,813.32 |
DisclosureSEC source: 0000899243-21-033643 · doc4.xml · nonDerivative · entry 7 DAWES KAREN A · CIK 0001261506 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,061 F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on June 8, 2021. F7 · price: $257.66 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $257.14 to $258.10, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| August 17, 2021 Filed Aug 18, 2021 20:16 UTC |
Hunt AnthonyDirector · Chief Executive Officer
|
GiftCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-033450 · doc4.xml · nonDerivative · entry 1 Hunt Anthony · CIK 0001606030 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 189,495 F1 · kind: The shares were disposed of in connection with a bona fide gift by the Reporting Person to a donor advised fund. Read SEC document |
| August 17, 2021 Filed Aug 19, 2021 20:42 UTC |
DAWES KAREN ADirector
|
SaleCommon Stock | 194 | $256.43 | $49,747.42 |
DisclosureSEC source: 0000899243-21-033643 · doc4.xml · nonDerivative · entry 6 DAWES KAREN A · CIK 0001261506 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,363 F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on June 8, 2021. Read SEC document |
| August 17, 2021 Filed Aug 19, 2021 20:42 UTC |
DAWES KAREN ADirector
|
SaleCommon Stock | 2,231 | $255.07 | $569,061.17 |
DisclosureSEC source: 0000899243-21-033643 · doc4.xml · nonDerivative · entry 5 DAWES KAREN A · CIK 0001261506 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,557 F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on June 8, 2021. F6 · price: $255.07 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $254.73 to $255.72, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| August 17, 2021 Filed Aug 19, 2021 20:42 UTC |
DAWES KAREN ADirector
|
SaleCommon Stock | 8,580 | $254.09 | $2,180,092.20 |
DisclosureSEC source: 0000899243-21-033643 · doc4.xml · nonDerivative · entry 4 DAWES KAREN A · CIK 0001261506 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,788 F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on June 8, 2021. F5 · price: $254.09 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $253.71 to $254.63, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| August 17, 2021 Filed Aug 19, 2021 20:42 UTC |
DAWES KAREN ADirector
|
SaleCommon Stock | 4,665 | $253.34 | $1,181,831.10 |
DisclosureSEC source: 0000899243-21-033643 · doc4.xml · nonDerivative · entry 3 DAWES KAREN A · CIK 0001261506 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,368 F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on June 8, 2021. F4 · price: $253.34 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $252.69 to $253.66, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| August 17, 2021 Filed Aug 19, 2021 20:42 UTC |
DAWES KAREN ADirector
|
SaleCommon Stock | 920 | $251.92 | $231,766.40 |
DisclosureSEC source: 0000899243-21-033643 · doc4.xml · nonDerivative · entry 2 DAWES KAREN A · CIK 0001261506 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,033 F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on June 8, 2021. F3 · price: $251.92 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $251.66 to $252.48, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| August 17, 2021 Filed Aug 19, 2021 20:42 UTC |
DAWES KAREN ADirector
|
SaleCommon Stock | 924 | $251.15 | $232,062.60 |
DisclosureSEC source: 0000899243-21-033643 · doc4.xml · nonDerivative · entry 1 DAWES KAREN A · CIK 0001261506 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,953 F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on June 8, 2021. F2 · price: $251.15 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $250.63 to $251.48, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| August 04, 2021 Filed Aug 5, 2021 23:33 UTC |
RYAN THOMAS F JRDirector
|
SaleCommon Stock | 780 | $250.50 | $195,390.00 |
DisclosureSEC source: 0000899243-21-031820 · doc4.xml · nonDerivative · entry 1 RYAN THOMAS F JR · CIK 0001263366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 971 Read SEC document |
| July 20, 2021 Filed Jul 23, 2021 00:25 UTC |
DAWES KAREN ADirector
|
SaleCommon Stock | 614 | $203.11 | $124,709.54 |
DisclosureSEC source: 0000899243-21-029561 · doc4.xml · nonDerivative · entry 4 DAWES KAREN A · CIK 0001261506 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,877 F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on June 8, 2021. F5 · price: $203.11 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $202.78 to $203.55, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| July 20, 2021 Filed Jul 23, 2021 00:25 UTC |
DAWES KAREN ADirector
|
SaleCommon Stock | 2,877 | $202.29 | $581,988.33 |
DisclosureSEC source: 0000899243-21-029561 · doc4.xml · nonDerivative · entry 3 DAWES KAREN A · CIK 0001261506 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,491 F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on June 8, 2021. F4 · price: $202.29 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $201.76 to $202.73, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| July 20, 2021 Filed Jul 23, 2021 00:25 UTC |
DAWES KAREN ADirector
|
SaleCommon Stock | 806 | $201.37 | $162,304.22 |
DisclosureSEC source: 0000899243-21-029561 · doc4.xml · nonDerivative · entry 2 DAWES KAREN A · CIK 0001261506 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,368 F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on June 8, 2021. F3 · price: $201.37 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $200.76 to $201.73, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| July 20, 2021 Filed Jul 23, 2021 00:25 UTC |
DAWES KAREN ADirector
|
SaleCommon Stock | 288 | $200.01 | $57,602.88 |
DisclosureSEC source: 0000899243-21-029561 · doc4.xml · nonDerivative · entry 1 DAWES KAREN A · CIK 0001261506 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,174 F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on June 8, 2021. F2 · price: $200.01 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $199.56 to $200.20, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| July 13, 2021 Filed Jul 15, 2021 21:17 UTC |
DAWES KAREN ADirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,929 | $0.00 Strike: $41.19 | $0.00 |
DisclosureSEC source: 0000899243-21-028505 · doc4.xml · derivative · entry 3 DAWES KAREN A · CIK 0001261506 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,929 shares Expires 2025-07-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| July 13, 2021 Filed Jul 15, 2021 21:17 UTC |
DAWES KAREN ADirector
|
SaleCommon Stock | 1,520 | $202.23 | $307,389.60 |
DisclosureSEC source: 0000899243-21-028505 · doc4.xml · nonDerivative · entry 2 DAWES KAREN A · CIK 0001261506 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,462 F1 · price: $202.23 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $201.27 to $204.02, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| July 13, 2021 Filed Jul 15, 2021 21:17 UTC |
DAWES KAREN ADirector
|
Exercise / conversionCommon Stock | 2,929 | $41.19 | $120,645.51 |
DisclosureSEC source: 0000899243-21-028505 · doc4.xml · nonDerivative · entry 1 DAWES KAREN A · CIK 0001261506 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,982 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 13, 2021 Filed Jul 22, 2021 22:53 UTC Amendment |
DAWES KAREN ADirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,929 | $0.00 Strike: $41.19 | $0.00 |
DisclosureSEC source: 0000899243-21-029533 · doc4a.xml · derivative · entry 6 DAWES KAREN A · CIK 0001261506 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,929 shares Expires 2025-07-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| July 13, 2021 Filed Jul 22, 2021 22:53 UTC Amendment |
DAWES KAREN ADirector
|
SaleCommon Stock | 5 | $204.02 | $1,020.10 |
DisclosureSEC source: 0000899243-21-029533 · doc4a.xml · nonDerivative · entry 5 DAWES KAREN A · CIK 0001261506 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,462 F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on June 8, 2021. F5 · price: $204.02 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $204.01 to $204.07, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| July 13, 2021 Filed Jul 22, 2021 22:53 UTC Amendment |
DAWES KAREN ADirector
|
SaleCommon Stock | 444 | $203.09 | $90,171.96 |
DisclosureSEC source: 0000899243-21-029533 · doc4a.xml · nonDerivative · entry 4 DAWES KAREN A · CIK 0001261506 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,467 F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on June 8, 2021. F4 · price: $203.09 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $202.86 to $203.50, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| July 13, 2021 Filed Jul 22, 2021 22:53 UTC Amendment |
DAWES KAREN ADirector
|
SaleCommon Stock | 630 | $202.29 | $127,442.70 |
DisclosureSEC source: 0000899243-21-029533 · doc4a.xml · nonDerivative · entry 3 DAWES KAREN A · CIK 0001261506 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,911 F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on June 8, 2021. F3 · price: $202.29 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $201.77 to $202.68, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| July 13, 2021 Filed Jul 22, 2021 22:53 UTC Amendment |
DAWES KAREN ADirector
|
SaleCommon Stock | 441 | $201.27 | $88,760.07 |
DisclosureSEC source: 0000899243-21-029533 · doc4a.xml · nonDerivative · entry 2 DAWES KAREN A · CIK 0001261506 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,541 F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on June 8, 2021. F2 · price: $201.27 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $200.77 to $201.67, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| July 13, 2021 Filed Jul 22, 2021 22:53 UTC Amendment |
DAWES KAREN ADirector
|
Exercise / conversionCommon Stock | 2,929 | $41.19 | $120,645.51 |
DisclosureSEC source: 0000899243-21-029533 · doc4a.xml · nonDerivative · entry 1 DAWES KAREN A · CIK 0001261506 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,982 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 22:48 UTC |
KURIYEL RALFSenior VP, R&D
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,045 | $0.00 Strike: $86.10 | $0.00 |
DisclosureSEC source: 0000899243-21-023674 · doc4.xml · derivative · entry 5 KURIYEL RALF · CIK 0001733143 · Senior VP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,092 Underlying: Common Stock · 1,045 shares Expires 2030-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 1,045 of the shares underlying the option have vested. The remaining shares vest as follows: 1,046 shares on February 27, 2022 and February 27, 2023. Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 22:48 UTC |
KURIYEL RALFSenior VP, R&D
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,557 | $0.00 Strike: $59.52 | $0.00 |
DisclosureSEC source: 0000899243-21-023674 · doc4.xml · derivative · entry 4 KURIYEL RALF · CIK 0001733143 · Senior VP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,354 Underlying: Common Stock · 2,557 shares Expires 2029-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 2,707 of the shares underlying the option have vested. The remaining 1,354 shares shall vest on February 28, 2022. Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 22:48 UTC |
KURIYEL RALFSenior VP, R&D
|
SaleCommon Stock | 6,802 | $189.19 | $1,286,870.38 |
DisclosureSEC source: 0000899243-21-023674 · doc4.xml · nonDerivative · entry 3 KURIYEL RALF · CIK 0001733143 · Senior VP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,355 F1 · price: $189.19 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $188.70 to $189.59, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 22:48 UTC |
KURIYEL RALFSenior VP, R&D
|
Exercise / conversionCommon Stock | 1,045 | $86.10 | $89,974.50 |
DisclosureSEC source: 0000899243-21-023674 · doc4.xml · nonDerivative · entry 2 KURIYEL RALF · CIK 0001733143 · Senior VP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,157 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 22:48 UTC |
KURIYEL RALFSenior VP, R&D
|
Exercise / conversionCommon Stock | 2,557 | $59.52 | $152,192.64 |
DisclosureSEC source: 0000899243-21-023674 · doc4.xml · nonDerivative · entry 1 KURIYEL RALF · CIK 0001733143 · Senior VP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,112 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 19, 2021 Filed May 21, 2021 01:00 UTC |
Hunt AnthonyDirector · Chief Executive Officer
|
SaleCommon Stock | 380 | $175.15 | $66,557.00 |
DisclosureSEC source: 0000899243-21-020294 · doc4.xml · nonDerivative · entry 8 Hunt Anthony · CIK 0001606030 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 190,495 F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on December 9, 2020. F9 · price: $175.15 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $174.98 to $175.53, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| May 19, 2021 Filed May 21, 2021 01:00 UTC |
Hunt AnthonyDirector · Chief Executive Officer
|
SaleCommon Stock | 2,819 | $174.41 | $491,661.79 |
DisclosureSEC source: 0000899243-21-020294 · doc4.xml · nonDerivative · entry 7 Hunt Anthony · CIK 0001606030 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 190,875 F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on December 9, 2020. F8 · price: $174.41 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $173.98 to $174.95, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| May 19, 2021 Filed May 21, 2021 01:00 UTC |
Hunt AnthonyDirector · Chief Executive Officer
|
SaleCommon Stock | 1,560 | $173.19 | $270,176.40 |
DisclosureSEC source: 0000899243-21-020294 · doc4.xml · nonDerivative · entry 6 Hunt Anthony · CIK 0001606030 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 193,694 F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on December 9, 2020. F7 · price: $173.19 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $172.96 to $173.83, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| May 19, 2021 Filed May 21, 2021 01:00 UTC |
Hunt AnthonyDirector · Chief Executive Officer
|
SaleCommon Stock | 3,036 | $172.52 | $523,770.72 |
DisclosureSEC source: 0000899243-21-020294 · doc4.xml · nonDerivative · entry 5 Hunt Anthony · CIK 0001606030 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195,254 F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on December 9, 2020. F6 · price: $172.52 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $171.96 to $172.91, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| May 19, 2021 Filed May 21, 2021 01:00 UTC |
Hunt AnthonyDirector · Chief Executive Officer
|
SaleCommon Stock | 3,420 | $171.32 | $585,914.40 |
DisclosureSEC source: 0000899243-21-020294 · doc4.xml · nonDerivative · entry 4 Hunt Anthony · CIK 0001606030 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 198,290 F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on December 9, 2020. F5 · price: $171.32 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $170.93 to $171.86, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| May 19, 2021 Filed May 21, 2021 01:00 UTC |
Hunt AnthonyDirector · Chief Executive Officer
|
SaleCommon Stock | 7,911 | $170.28 | $1,347,085.08 |
DisclosureSEC source: 0000899243-21-020294 · doc4.xml · nonDerivative · entry 3 Hunt Anthony · CIK 0001606030 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 201,710 F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on December 9, 2020. F4 · price: $170.28 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $169.91 to $170.88, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| May 19, 2021 Filed May 21, 2021 01:00 UTC |
Hunt AnthonyDirector · Chief Executive Officer
|
SaleCommon Stock | 2,529 | $169.45 | $428,539.05 |
DisclosureSEC source: 0000899243-21-020294 · doc4.xml · nonDerivative · entry 2 Hunt Anthony · CIK 0001606030 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 209,621 F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on December 9, 2020. F3 · price: $169.45 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $168.90 to $169.88, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| May 19, 2021 Filed May 21, 2021 01:00 UTC |
Hunt AnthonyDirector · Chief Executive Officer
|
SaleCommon Stock | 612 | $168.29 | $102,993.48 |
DisclosureSEC source: 0000899243-21-020294 · doc4.xml · nonDerivative · entry 1 Hunt Anthony · CIK 0001606030 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 212,150 F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on December 9, 2020. F2 · price: $168.29 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $167.61 to $168.58, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| May 14, 2021 Filed May 18, 2021 11:52 UTC |
Gebski ChristineSee Remarks
|
SaleCommon Stock | 445 | $172.25 | $76,651.25 |
DisclosureSEC source: 0000899243-21-019723 · doc4.xml · nonDerivative · entry 1 Gebski Christine · CIK 0001849585 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,695 F1 · kind: Sale of shares in the open market to cover tax liability resulting from the release of restricted stock units. F2 · price: $172.25 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $172.16 to $172.32, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| May 14, 2021 Filed May 18, 2021 11:50 UTC |
KURIYEL RALFSenior VP, R&D
|
SaleCommon Stock | 710 | $172.29 | $122,325.90 |
DisclosureSEC source: 0000899243-21-019721 · doc4.xml · nonDerivative · entry 1 KURIYEL RALF · CIK 0001733143 · Senior VP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,555 F1 · kind: Sale of shares in the open market to cover tax liability resulting from the release of restricted stock units. F2 · price: $172.29 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $172.26 to $172.40, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| May 14, 2021 Filed May 18, 2021 11:49 UTC |
Snodgres JonChief Financial Officer
|
SaleCommon Stock | 470 | $172.60 | $81,122.00 |
DisclosureSEC source: 0000899243-21-019720 · doc4.xml · nonDerivative · entry 1 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,893 F1 · kind: Sale of shares in the open market to cover tax liability resulting from the release of restricted stock units. F2 · price: $172.60 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $172.59 to $172.67, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| May 13, 2021 Filed May 18, 2021 01:59 UTC |
EGLINTON MANNER CARRIEDirector
|
GrantStock Option (Right to Buy) · Derivative | 1,151 | $0.00 Strike: $169.65 | $0.00 |
DisclosureSEC source: 0000899243-21-019713 · doc4.xml · derivative · entry 2 EGLINTON MANNER CARRIE · CIK 0001696776 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,151 Underlying: Common Stock · 1,151 shares Expires 2031-05-13 F2 · derivative.exercise_date: Award vests in full on the earlier of May 13, 2022, one year from grant date, or on the date of the next annual meeting of the Company's shareholders, which has not yet been determined. Read SEC document |
| May 13, 2021 Filed May 18, 2021 01:59 UTC |
EGLINTON MANNER CARRIEDirector
|
GrantCommon Stock | 457 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-019713 · doc4.xml · nonDerivative · entry 1 EGLINTON MANNER CARRIE · CIK 0001696776 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 457 F1 · shares: Ms. Eglinton Manner was awarded 457 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on the earlier of May 13, 2022, one year from the grant date, or the date of the next annual meeting of the Company's shareholders, which has not yet been determined. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. Read SEC document |
| May 13, 2021 Filed May 18, 2021 01:57 UTC |
MUIR GLENN PDirector
|
GrantStock Option (Right to Buy) · Derivative | 1,151 | $0.00 Strike: $169.65 | $0.00 |
DisclosureSEC source: 0000899243-21-019712 · doc4.xml · derivative · entry 2 MUIR GLENN P · CIK 0001181190 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,151 Underlying: Common Stock · 1,151 shares Expires 2031-05-13 F2 · derivative.exercise_date: Award vests in full on the earlier of May 13, 2022, one year from grant date, or on the date of the next annual meeting of the Company's shareholders, which has not yet been determined. Read SEC document |
| May 13, 2021 Filed May 18, 2021 01:57 UTC |
MUIR GLENN PDirector
|
GrantCommon Stock | 457 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-019712 · doc4.xml · nonDerivative · entry 1 MUIR GLENN P · CIK 0001181190 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,362 F1 · shares: Mr. Muir was awarded 457 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on the earlier of May 13, 2022, one year from the grant date, or the date of the next annual meeting of the Company's shareholders, which has not yet been determined. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. Read SEC document |
| May 13, 2021 Filed May 18, 2021 01:56 UTC |
BARTHELEMY NICOLASDirector
|
GrantStock Option (Right to Buy) · Derivative | 1,151 | $0.00 Strike: $169.65 | $0.00 |
DisclosureSEC source: 0000899243-21-019710 · doc4.xml · derivative · entry 2 BARTHELEMY NICOLAS · CIK 0001283576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,151 Underlying: Common Stock · 1,151 shares Expires 2031-05-13 F2 · derivative.exercise_date: Award vests in full on the earlier of May 13, 2022, one year from grant date, or on the date of the next annual meeting of the Company's shareholders, which has not yet been determined. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.